| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.565 | - | - | - | 516 | 0 | 0 | 126 | 0 | 0 |
| Total Income - EUR | 2.565 | - | - | - | 516 | 0 | 0 | 126 | 0 | 0 |
| Total Expenses - EUR | 4.810 | - | - | - | 1.988 | 916 | 1.434 | 1.752 | 515 | 485 |
| Gross Profit/Loss - EUR | -2.245 | - | - | - | -1.472 | -916 | -1.434 | -1.626 | -515 | -485 |
| Net Profit/Loss - EUR | -2.299 | - | - | - | -1.483 | -916 | -1.434 | -1.630 | -515 | -485 |
| Employees | 1 | - | - | - | 0 | 0 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Alex Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 52 | - | - | - | 4.979 | 4.012 | 3.198 | 2.608 | 2.085 | 1.588 |
| Current Assets | 924 | - | - | - | 617 | 613 | 600 | 616 | 614 | 610 |
| Inventories | 0 | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 13 | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 911 | - | - | - | 617 | 613 | 600 | 616 | 614 | 610 |
| Shareholders Funds | -39.169 | - | - | - | -47.389 | -47.407 | -47.790 | -49.568 | -49.933 | -50.139 |
| Social Capital | 45 | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 43.646 | - | - | - | 52.985 | 52.033 | 51.588 | 52.792 | 52.632 | 52.338 |
| Income in Advance | 0 | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Alex Med S.r.l.